title: 'Stroke-like syndrome' caused by intrathecal methotrexate in patients treated during the UKALL 2003 trial.
authors.forename: J
authors.initials: J
authors.lastname: Bond
authors.forename: R
authors.initials: R
authors.lastname: Hough
authors.forename: J
authors.initials: J
authors.lastname: Moppett
authors.forename: A
authors.initials: A
authors.lastname: Vora
authors.forename: C
authors.initials: C
authors.lastname: Mitchell
authors.forename: N
authors.initials: N
authors.lastname: Goulden
mesh_terms: D000293:Adolescent; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D008297:Male; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D020521:Stroke / Q000139:chemically induced*; D006113:United Kingdom
chemical_list: D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate